We are live on ! Find out more
BIOL icon

Biolase

Delisted

BIOL was delisted on the 18th of June, 2024.

34 hedge funds and large institutions have $40.1M invested in Biolase in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,445% more capital inflows, than outflows

Capital inflows: $10.1M | Capital outflows: $653K

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

10% more funds holding

Funds holding: 31 → 34 (+3)

8.79% more ownership

Funds ownership: 33.61% → 42.4% (+8.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
3
Increased
8
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BIOL Hedge Fund Activity: Q4 2016 in Review

34 of the 4,009 institutional investors tracked by Wall St. Rank reported a position in Biolase (BIOL) for Q4 2016, worth a combined $40.1M — up 7.1% from $37.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIOL positions and 0 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $8.45M. The largest seller was Consonance Capital Management, cutting an estimated $534K.

  • 34 institutional investors held Biolase (BIOL) as of Q4 2016, up from 31 in Q3 2016.
  • Funds reported $40.1M of Biolase stock for Q4 2016, up 7.1% quarter-over-quarter.
  • 3 funds opened new Biolase positions in Q4 2016 and 0 closed out, a net change of +3 holders.
  • The largest Biolase buyer in Q4 2016 was Camber Capital Management, an estimated $8.45M added.
  • The largest Biolase seller in Q4 2016 was Consonance Capital Management, an estimated $534K sold.

Based on aggregated 13F filings for Q4 2016.